SGLT2 inhibitors for patients with type 2 diabetes and CKD: a narrative review
Sodium‐glucose co-transporter 2 (SGLT2) inhibitors have recently emerged as an effective means to protect kidney function in people with type 2 diabetes and chronic kidney disease (CKD). In this review, we explore the role of SGLT2 inhibition in these individuals. SGLT2 inhibitors specifically act t...
Uloženo v:
| Hlavní autoři: | , , , , |
|---|---|
| Médium: | Revisão |
| Jazyk: | angličtina |
| Vydáno: |
2023
|
| On-line přístup: | https://doi.org/10.1530/ec-23-0005 https://ec.bioscientifica.com/downloadpdf/journals/ec/aop/ec-23-0005/ec-23-0005.pdf |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|